Carol Saunders

Carol Saunders

Auto-generated profile, based on publicly available information

Carol Saunders

Department of Pathology and Laboratory Medicine Children's Mercy Hospital Kansas City Missouri USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2015 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
ITIsabelle Thiffault
Isabelle Thiffault
DSDavid J. Speca
David J. Speca
DADaniel C. Austin
Daniel C. Austin
MCMelanie M. Cobb
Melanie M. Cobb
KEKenneth S. Eum
Kenneth S. Eum
JSJon T. Sack
Jon T. Sack
The epileptic encephalopathies are a group of highly heterogeneous genetic disorders. The majority of disease-causing mutations alter genes encoding voltage-gated ion channels, neurotransmitter receptors, or synaptic proteins. We have identified a novel de novo pathogenic K+ channel variant in an idiopathic epileptic encephalopathy family. Here, we report the effects of this mutation on channel function and heterologous expression in cell lines. We present a case report of infantile epileptic encephalopathy in a young girl, and trio-exome sequencing to determine the genetic etiology of her disorder. The patient was heterozygous for a de novo missense variant in the coding region of the KCNB1 gene, c.1133T>C. The variant encodes a V378A mutation in the α subunit of the Kv2.1 voltage-gated K+ channel, which is expressed at high levels in central neurons and is an important regulator of neuronal excitability. We found that expression of the V378A variant results in voltage-activated currents that are sensitive to the selective Kv2 channel blocker guangxitoxin-1E. These voltage-activated Kv2.1 V378A currents were nonselective among monovalent cations. Striking cell background–dependent differences in expression and subcellular localization of the V378A mutation were observed in heterologous cells. Further, coexpression of V378A subunits and wild-type Kv2.1 subunits reciprocally affects their respective trafficking characteristics. A recent study reported epileptic encephalopathy-linked missense variants that render Kv2.1 a tonically activated, nonselective cation channel that is not voltage activated. Our findings strengthen the correlation between mutations that result in loss of Kv2.1 ion selectivity and development of epileptic encephalopathy. However, the strong voltage sensitivity of currents from the V378A mutant indicates that the loss of voltage-sensitive gating seen in all other reported disease mutants is not required for an epileptic encephalopathy phenotype. In addition to electrophysiological differences, we suggest that defects in expression and subcellular localization of Kv2.1 V378A channels could contribute to the pathophysiology of this KCNB1 variant.

1 February 2015 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
CSCarol Saunders
Carol Saunders
LSLaurie Smith
Laurie Smith
FWFlemming Wibrand
Flemming Wibrand
KRKirstine Ravn
Kirstine Ravn
Peter BrossPeter Bross
Peter Bross
EOElsebet Ostergaard
Elsebet Ostergaard

1 September 2013 in Genomics
Verified
Journal Article
Closed access
DDDarrell L. Dinwiddie
Darrell L. Dinwiddie
LSLaurie Smith
Laurie Smith
NMNeil A. Miller
Neil A. Miller
AAAndrea M. Atherton
Andrea M. Atherton
EFEmily G. Farrow
Emily G. Farrow
SKStephen F. Kingsmore
Stephen F. Kingsmore

26 March 2016 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
ITIsabelle Thiffault
Isabelle Thiffault
EFEmily Farrow
Emily Farrow
LSLaurie Smith
Laurie Smith
JLJennifer Lowry
Jennifer Lowry
LZLee Zellmer
Lee Zellmer
CSCarol Saunders
Carol Saunders

1 January 2012 in Genome Medicine
Verified
Journal Article
Open access
PDF file
SKStephen F Kingsmore
Stephen F Kingsmore
JLJohn David Lantos
John David Lantos
DDDarrell L Dinwiddie
Darrell L Dinwiddie
NMNeil A Miller
Neil A Miller
SSSarah E Soden
Sarah E Soden
CSCarol J Saunders
Carol J Saunders
A recent report by the World Health Organization calls for implementation of community genetics programs in low- and middle-income countries (LMICs). Their focus is prevention of congenital disorders and genetic diseases at the population level, in addition to providing genetics services, including diagnosis and counseling. The proposed strategies include both newborn screening and population screening for carrier detection, in addition to lowering the incidence of congenital disorders and genetic diseases through the removal of environmental factors. In this article, we consider the potential impact of such testing on global health and highlight the near-term relevance of next-generation sequencing (NGS) and bioinformatic approaches to their implementation. Key attributes of NGS for community genetics programs are homogeneous approach, high multiplexing of diseases and samples, as well as rapidly falling costs of new technologies. In the near future, we estimate that appropriate use of population-specific test panels could cost as little as $10 for 10 Mendelian disorders and could have a major impact on diseases that currently affect 2% of children worldwide. However, the successful deployment of this technological innovation in LMICs will require high value for human life, thoughtful implementation, and autonomy of individual decisions, supported by appropriate genetic counseling and community education.

2 September 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JLJuan Li
Juan Li
WLWei Te Lei
Wei Te Lei
PZPeng Zhang
Peng Zhang
FRFranck Rapaport
Franck Rapaport
YSYoann Seeleuthner
Yoann Seeleuthner
BBBertrand Boisson
Bertrand Boisson
Autosomal dominant (AD) NFKB1 deficiency is thought to be the most common genetic etiology of common variable immunodeficiency (CVID). However, the causal link between NFKB1 variants and CVID has not been demonstrated experimentally and genetically, and there has been insufficient biochemical characterization and enrichment analysis. We show that the cotransfection of NFKB1-deficient HEK293T cells (lacking both p105 and its cleaved form p50) with a κB reporter, NFKB1/p105, and a homodimerization-defective RELA/p65 mutant results in p50:p65 heterodimer–dependent and p65:p65 homodimer–independent transcriptional activation. We found that 59 of the 90 variants in patients with CVID or related conditions were loss of function or hypomorphic. By contrast, 258 of 260 variants in the general population or patients with unrelated conditions were neutral. None of the deleterious variants displayed negative dominance. The enrichment in deleterious NFKB1 variants of patients with CVID was selective and highly significant (P = 2.78 × 10−15). NFKB1 variants disrupting NFKB1/p50 transcriptional activity thus underlie AD CVID by haploinsufficiency, whereas neutral variants in this assay should not be considered causal.